Device Sports Medicine

Gps III Platelet Concentration System

Payments companies reported to CMS as associated with Gps III Platelet Concentration System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$9,327associated payments (2023-2025)
248clinicians with associated payments
1company reporting

By year

2023 $4,459
2024 $4,039
2025 $829

Payments reported as associated with Gps III Platelet Concentration System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $2,453
Physician Assistant $1,768
Surgical $682
Sports Medicine (Orthopaedic Surgery) $608
Sports Medicine (Family Medicine) $581
Medical $364

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gps III Platelet Concentration System

These are the largest totals companies reported as associated with Gps III Platelet Concentration System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Rachael Scharchburg Fort Worth, TX Surgical $164.03
Holly Chu Fort Worth, TX Surgical $164.02
Joseph Daniels Fort Worth, TX Orthopaedic Surgery $160.92
Ethan Jose Santa Cruz, CA Sports Medicine (Family Medicine) $149.85
Michael Maxted Oklahoma City, OK Sports Medicine (Orthopaedic Surgery) $149.85
Amber Purvine Oklahoma City, OK Physician Assistant $149.85
Joel Tupper Oklahoma City, OK Orthopaedic Surgery $149.85
Lisa Kippenberger Oklahoma City, OK Physician Assistant $149.85
Jennifer Li Edmond, OK Family Medicine $149.85
Daniel Jones Oklahoma City, OK Orthopaedic Surgery $149.84

Prescribed Gps III Platelet Concentration System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.